Picture of Alpine Immune Sciences logo

ALPN Alpine Immune Sciences Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Annual balance sheet for Alpine Immune Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments40.5106162238327
Net Total Accounts Receivable
Net Total Receivables0.6860.38825.30.7090.749
Prepaid Expenses
Total Other Current Assets
Total Current Assets42.3107192241330
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment11.511.210.69.88.99
Long Term Investments
Other Long Term Assets
Total Assets54.1144256287380
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities8.6841.269.85842
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities24.681.913510751.9
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity29.562.2121179328
Total Liabilities & Shareholders' Equity54.1144256287380
Total Common Shares Outstanding